Labetalol Hydrochloride NDC 71335-1242

Product information

Brand name (proprietary)

Labetalol Hydrochloride

Generic name (nonproprietary)

labetalol hydrochloride

Active ingredients

Labetalol hydrochloride — 200 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207743

Marketing start

Dec 5, 2017

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 71335-1242_8d4c15db-5ffc-40eb-b025-9f501352c455SPL ID 8d4c15db-5ffc-40eb-b025-9f501352c455SPL set ID 9c3bb751-c425-43ff-b530-2460b568b689RxCUI 896762UNII 1GEV3BAW9J

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335124201 followed by a unit qualifier and the quantity Copy

Package 71335-1242-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 207743

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.